JPWO2018191479A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2018191479A5 JPWO2018191479A5 JP2019555854A JP2019555854A JPWO2018191479A5 JP WO2018191479 A5 JPWO2018191479 A5 JP WO2018191479A5 JP 2019555854 A JP2019555854 A JP 2019555854A JP 2019555854 A JP2019555854 A JP 2019555854A JP WO2018191479 A5 JPWO2018191479 A5 JP WO2018191479A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- amino acid
- acid sequence
- tslp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2023080295A JP2023099233A (ja) | 2017-04-12 | 2023-05-15 | 抗tslp抗体による喘息治療 |
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762484864P | 2017-04-12 | 2017-04-12 | |
US62/484,864 | 2017-04-12 | ||
US201762553575P | 2017-09-01 | 2017-09-01 | |
US201762553477P | 2017-09-01 | 2017-09-01 | |
US62/553,575 | 2017-09-01 | ||
US62/553,477 | 2017-09-01 | ||
PCT/US2018/027271 WO2018191479A1 (en) | 2017-04-12 | 2018-04-12 | Treatment of asthma with anti-tslp antibody |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023080295A Division JP2023099233A (ja) | 2017-04-12 | 2023-05-15 | 抗tslp抗体による喘息治療 |
Publications (4)
Publication Number | Publication Date |
---|---|
JP2020516647A JP2020516647A (ja) | 2020-06-11 |
JP2020516647A5 JP2020516647A5 (he) | 2021-05-20 |
JPWO2018191479A5 true JPWO2018191479A5 (he) | 2022-11-22 |
JP7330896B2 JP7330896B2 (ja) | 2023-08-22 |
Family
ID=62092313
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019555854A Active JP7330896B2 (ja) | 2017-04-12 | 2018-04-12 | 抗tslp抗体による喘息治療 |
JP2023080295A Pending JP2023099233A (ja) | 2017-04-12 | 2023-05-15 | 抗tslp抗体による喘息治療 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023080295A Pending JP2023099233A (ja) | 2017-04-12 | 2023-05-15 | 抗tslp抗体による喘息治療 |
Country Status (20)
Country | Link |
---|---|
US (2) | US10828365B2 (he) |
EP (1) | EP3609917A1 (he) |
JP (2) | JP7330896B2 (he) |
KR (2) | KR20240070727A (he) |
CN (1) | CN110573525A (he) |
AU (1) | AU2018253118A1 (he) |
BR (1) | BR112019021482A2 (he) |
CA (1) | CA3059364A1 (he) |
CL (1) | CL2019002897A1 (he) |
CO (1) | CO2019011462A2 (he) |
IL (1) | IL269791B (he) |
JO (1) | JOP20190243A1 (he) |
MX (1) | MX2019012158A (he) |
PE (1) | PE20200484A1 (he) |
PH (1) | PH12019502331A1 (he) |
SG (1) | SG11201909322VA (he) |
TN (1) | TN2019000289A1 (he) |
TW (1) | TW201838652A (he) |
UY (1) | UY37676A (he) |
WO (1) | WO2018191479A1 (he) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ740067A (en) * | 2015-09-09 | 2021-07-30 | Novartis Ag | Thymic stromal lymphopoietin (tslp)-binding molecules and methods of using the molecules |
KR20220016897A (ko) * | 2019-06-04 | 2022-02-10 | 지앙수 헨그루이 메디슨 컴퍼니 리미티드 | 흉선 기질 림포포이에틴에 결합할 수 있는 항체 및 이의 용도 |
KR20220033504A (ko) * | 2019-07-11 | 2022-03-16 | 타보텍 바이오테라퓨틱스 (홍콩) 리미티드 | 흉선 기질 림프포이에틴(tslp)-수용체 신호전달을 방해하는 제제 |
CN117467007A (zh) * | 2019-09-04 | 2024-01-30 | 正大天晴药业集团股份有限公司 | 结合tslp的抗体及其用途 |
JP2022554249A (ja) * | 2019-10-28 | 2022-12-28 | メドイミューン・リミテッド | 胸腺間質性リンパ球新生因子(tslp)結合抗体の乾燥粉末製剤及びその使用方法 |
EP4047019A4 (en) * | 2019-12-13 | 2023-11-15 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | ANTI-TSLP ANTIBODIES AND USES THEREOF |
TW202140550A (zh) | 2020-01-29 | 2021-11-01 | 瑞士商諾華公司 | 使用抗tslp抗體治療炎性或阻塞性氣道疾病之方法 |
US20230073888A1 (en) * | 2020-02-13 | 2023-03-09 | Amgen Inc. | Treatment of atopic dermatitis with anti-tslp antibody |
CN115279404A (zh) * | 2020-02-13 | 2022-11-01 | 安进公司 | 人抗tslp抗体的配制品及治疗炎性疾病的方法 |
JP2023513833A (ja) * | 2020-02-18 | 2023-04-03 | アムジェン インコーポレイテッド | ヒト抗tslp抗体の製剤及びそれを使用する方法 |
TW202229339A (zh) * | 2020-12-03 | 2022-08-01 | 大陸商江蘇恒瑞醫藥股份有限公司 | 結合胸腺基質淋巴細胞生成素的抗體及其應用 |
CN113501878B (zh) * | 2021-02-03 | 2022-12-02 | 北京智仁美博生物科技有限公司 | 针对人tslp的多种抗体及其用途 |
CN114853888B (zh) * | 2021-02-05 | 2023-11-03 | 上海洛启生物医药技术有限公司 | 抗tslp纳米抗体及其应用 |
EP4302778A1 (en) * | 2021-03-03 | 2024-01-10 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Pharmaceutical composition containing anti-tslp antibody |
IL307651A (he) * | 2021-04-19 | 2023-12-01 | Medimmune Ltd | Fab אנטי-tslp עם יציבות משופרת |
US20240182558A1 (en) | 2021-04-23 | 2024-06-06 | Amgen Inc. | Modified anti-tslp antibodies |
AU2022262421A1 (en) | 2021-04-23 | 2023-10-19 | Amgen Inc. | Anti-tslp antibody compositions and uses thereof |
CN113683694B (zh) * | 2021-09-03 | 2022-05-13 | 江苏荃信生物医药股份有限公司 | 一种抗人tslp单克隆抗体及其应用 |
CN116217724B (zh) * | 2021-12-02 | 2023-10-27 | 北京东方百泰生物科技股份有限公司 | 一种抗tslp的单克隆抗体、其抗原结合片段及其应用 |
WO2024092064A1 (en) | 2022-10-26 | 2024-05-02 | Amgen Inc. | Anti-tslp antibody compositions and uses thereof |
CN117551195B (zh) * | 2024-01-12 | 2024-04-09 | 杭州畅溪制药有限公司 | 靶向tslp的vhh纳米抗体及其应用 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
SG48759A1 (en) | 1990-01-12 | 2002-07-23 | Abgenix Inc | Generation of xenogenic antibodies |
KR100272077B1 (ko) | 1990-08-29 | 2000-11-15 | 젠팜인터내셔날,인코포레이티드 | 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물 |
WO1994002602A1 (en) | 1992-07-24 | 1994-02-03 | Cell Genesys, Inc. | Generation of xenogeneic antibodies |
KR100654645B1 (ko) | 1995-04-27 | 2007-04-04 | 아브게닉스, 인크. | 면역화된 제노마우스 유래의 인간 항체 |
US7982016B2 (en) * | 2007-09-10 | 2011-07-19 | Amgen Inc. | Antigen binding proteins capable of binding thymic stromal lymphopoietin |
US8359965B2 (en) | 2007-09-17 | 2013-01-29 | Oxford J Craig | Apparatus and method for broad spectrum radiation attenuation |
UY32038A (es) | 2008-08-08 | 2010-03-26 | Glaxo Wellcome Mfg Pte Ltd | Inmunoblobulinas anti-cd127 y sus usos |
BR112012010707B1 (pt) | 2009-11-04 | 2022-08-30 | Merck Sharp & Dohme Corp | Anticorpo ou fragmento de ligação ao antígeno do mesmo, composição, e, uso do anticorpo ou fragmento de ligação ao antígeno do mesmo |
AR082163A1 (es) | 2010-07-15 | 2012-11-14 | Hoffmann La Roche | Anticuerpos especificamente ligantes del tslpr humano y metodos de utilizacion de los mismos |
US9100245B1 (en) | 2012-02-08 | 2015-08-04 | Amazon Technologies, Inc. | Identifying protected media files |
US9306926B2 (en) | 2013-03-15 | 2016-04-05 | Brian A. Truong | User authentication using unique hidden identifiers |
JP6715767B2 (ja) * | 2013-10-23 | 2020-07-01 | ジェネンテック, インコーポレイテッド | 好酸球性疾患の診断及び治療方法 |
CA3090240A1 (en) * | 2014-08-08 | 2016-02-11 | Alector Llc | Anti-trem2 antibodies and methods of use thereof |
WO2016142426A1 (en) | 2015-03-11 | 2016-09-15 | Glaxosmithkline Intellectual Property Development Limited | Tslp binding proteins |
MY186352A (en) * | 2015-09-09 | 2021-07-15 | Novartis Ag | Thymic stromal lymphopoietin (tslp)-binding antibodies and methods of using the antibodies |
-
2017
- 2017-06-16 JO JOP/2019/0243A patent/JOP20190243A1/ar unknown
-
2018
- 2018-04-12 EP EP18721605.6A patent/EP3609917A1/en active Pending
- 2018-04-12 TN TNP/2019/000289A patent/TN2019000289A1/en unknown
- 2018-04-12 BR BR112019021482-8A patent/BR112019021482A2/pt unknown
- 2018-04-12 AU AU2018253118A patent/AU2018253118A1/en active Pending
- 2018-04-12 CA CA3059364A patent/CA3059364A1/en active Pending
- 2018-04-12 WO PCT/US2018/027271 patent/WO2018191479A1/en unknown
- 2018-04-12 IL IL269791A patent/IL269791B/he unknown
- 2018-04-12 US US15/951,602 patent/US10828365B2/en active Active
- 2018-04-12 TW TW107112622A patent/TW201838652A/zh unknown
- 2018-04-12 PE PE2019002026A patent/PE20200484A1/es unknown
- 2018-04-12 CN CN201880026131.3A patent/CN110573525A/zh active Pending
- 2018-04-12 JP JP2019555854A patent/JP7330896B2/ja active Active
- 2018-04-12 MX MX2019012158A patent/MX2019012158A/es unknown
- 2018-04-12 UY UY0001037676A patent/UY37676A/es unknown
- 2018-04-12 KR KR1020247015858A patent/KR20240070727A/ko active Application Filing
- 2018-04-12 KR KR1020197033043A patent/KR102666879B1/ko active IP Right Grant
- 2018-04-12 SG SG11201909322V patent/SG11201909322VA/en unknown
-
2019
- 2019-10-11 CL CL2019002897A patent/CL2019002897A1/es unknown
- 2019-10-11 PH PH12019502331A patent/PH12019502331A1/en unknown
- 2019-10-16 CO CO2019011462A patent/CO2019011462A2/es unknown
-
2020
- 2020-11-09 US US17/093,387 patent/US20210052726A1/en active Pending
-
2023
- 2023-05-15 JP JP2023080295A patent/JP2023099233A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2020516647A5 (he) | ||
JPWO2018191479A5 (he) | ||
JP7330896B2 (ja) | 抗tslp抗体による喘息治療 | |
Md Yusof et al. | Targeting interleukin-6 in rheumatoid arthritis | |
Menzella et al. | Tailored therapy for severe asthma | |
AU2010248935B2 (en) | Methods and compositions for treating lupus | |
US10118967B2 (en) | Methods for treating rheumatoid arthritis by administering IL-6 receptor antibodies | |
JP2008502366A5 (he) | ||
JP2022512722A (ja) | 抗cd38抗体の皮下投与を提供する方法 | |
JP2020536097A5 (he) | ||
WO2017064615A1 (en) | Use of c5 inhibitors in transplant associated microangiopathy | |
Amini-Vaughan et al. | Therapeutic strategies for harnessing human eosinophils in allergic inflammation, hypereosinophilic disorders, and cancer | |
JP2021193121A (ja) | Il−17アンタゴニストを使用して汎発性膿疱性乾癬(gpp)を処置する方法 | |
JP2020520912A (ja) | 抗gitrアゴニスト抗体での癌の処置 | |
JP2024502471A (ja) | ピーナッツアレルギーを治療するための方法およびil-4rアンタゴニストを投与することによってピーナッツアレルゲン特異的免疫療法を増強する方法 | |
JP2023065390A (ja) | 治療用抗cd40リガンド抗体 | |
JP2018533588A (ja) | 治療パラダイム | |
US11827671B2 (en) | Methods for treating systemic sclerosis | |
TW202104266A (zh) | 使用抗psma/cd3抗體來治療腎癌之方法 | |
WO2021213523A1 (zh) | 抗pd-1抗体和抗ctla-4抗体的组合在预防或治疗癌症中的用途 | |
US20230398229A1 (en) | Antibody drug conjugates comprising sting agonists, combinations and methods of use | |
US20210230265A1 (en) | Methods for treating copd by administering an il-33 antagonist | |
JPWO2019231983A5 (he) | ||
JP2023506779A (ja) | 慢性移植片対宿主病の処置用抗体 | |
TW202112373A (zh) | 使用抗cd38抗體之組合療法 |